Literature DB >> 7377929

A supplementary instrumentation for posterior fusion of spine on scoliosis. A preliminary report.

W Küsswetter.   

Abstract

A new type of compression instrumentation for posterior spondylodesis in scoliosis is presented. The innovation in the instrumentation, which is composed of a compression and transverse stabilizing system, is the use of gear teeth on the threaded rods which can be moved by a special wrench with gear teeth transmission. The advantages of the new instrument are: 1. Simplification of the operative technique. 2. Reduction of operation time. 3. Improvement of correction effect through the balanced tension of the entire compression and transverse stabilization system.

Entities:  

Mesh:

Year:  1980        PMID: 7377929     DOI: 10.1007/bf01246146

Source DB:  PubMed          Journal:  Arch Orthop Trauma Surg        ISSN: 0344-8444


  4 in total

1.  Treatment of scoliosis. Correction and internal fixation by spine instrumentation.

Authors:  P R HARRINGTON
Journal:  J Bone Joint Surg Am       Date:  1962-06       Impact factor: 5.284

2.  [Surgical treatment of scoliosis using the Harrington instrumentation].

Authors:  H G Götze; M Immenkamp; H H Matthiass
Journal:  Z Orthop Ihre Grenzgeb       Date:  1971-09

3.  Blood loss after spinal instrumentation and fusion in scoliosis (Harrington procedure). Results using a radioactive tracer and an electronic blood volume computer: a preliminary report.

Authors:  R C Gardner
Journal:  Clin Orthop Relat Res       Date:  1970       Impact factor: 4.176

4.  Controlled hypotensive anesthesia in scoliosis surgery.

Authors:  T W McNeill; R L DeWald; K N Kuo; E J Bennett; M R Salem
Journal:  J Bone Joint Surg Am       Date:  1974-09       Impact factor: 5.284

  4 in total
  1 in total

1.  Advanced glycation end products, advanced oxidation protein products, and ferric reducing ability of plasma in patients with rheumatoid arthritis: a focus on activity scores.

Authors:  Seyed Reza Najafizadeh; Khatereh Amiri; Maryam Moghaddassi; Shaghayegh Khanmohammadi; Hossein Mirmiranpour; Manouchehr Nakhjavani
Journal:  Clin Rheumatol       Date:  2021-05-28       Impact factor: 2.980

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.